Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease (2010)
- Authors:
- Autor USP: BYDLOWSKI, SERGIO PAULO - FM
- Unidade: FM
- Subjects: DOENÇA DE VON WILLEBRAND; FATORES DE RISCO; HIPERTENSÃO PULMONAR; CARDIOPATIAS CONGÊNITAS
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
MAEDA, N Y et al. Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 jan. 2026. , 2010 -
APA
Maeda, N. Y., Bydlowski, S. P., Barreto, A. C., & Lopes, A. A. (2010). Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Maeda NY, Bydlowski SP, Barreto AC, Lopes AA. Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease. Clinics. 2010 ; 65 S67.[citado 2026 jan. 11 ] -
Vancouver
Maeda NY, Bydlowski SP, Barreto AC, Lopes AA. Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease. Clinics. 2010 ; 65 S67.[citado 2026 jan. 11 ] - Gametic phase disequilibrium between the syntenic multiallelic HTG4 and HMS3 markers widely used for parentage testing in Thoroughbred horses
- The effect of sildenafil in the multimeric composition of plasma von Willebrand factor in pulmonary hypertension: preliminary study
- Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
- Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody
- Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect
- Age-dependent likelihood o In Situ thrombosis in secondary pulmonary hypertension
- Detection of lung resistance-related protein (LRP) expression by RT-PCR in dogs with multicentric lymphoma
- Frequency of the mutations factor V leiden and prothrombin G20210A in patients with diagnosis of heparin induced thrombocytopenia
- Frequency of human platelet antigens (HPA) 1 to 13 in healthy population
- Freqüência das mutações fator V leiden, G2021OA no geneda protrombina e C677T no gene da metilenotetra-hidrofolato redutas em pacientes transplantados de fígado com e sem trombose vascular do enxerto e seus doadores
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
